Investigating health service use among PrEP users in Washington DC

A Mixed Methods Study of the Association Between LAI PrEP Initiation and Adherence, and Utilization of Health and Social Support Services Among Key Populations in Washington DC

Observational Us Helping Us, People Into Living, Inc. · NCT06046079

This study looks at how using PrEP affects the way people in Washington DC access health and social services over a year.

Quick facts

Study typeObservational
Enrollment100 (estimated)
Ages18 Years and up
SexAll
SponsorUs Helping Us, People Into Living, Inc. Academic / other
Locations1 site (Washington D.C., District of Columbia)
Trial IDNCT06046079 on ClinicalTrials.gov

What this trial studies

This observational study aims to explore how the use of pre-exposure prophylaxis (PrEP) influences the utilization of various health and social services among individuals in Washington DC. The primary hypothesis is that individuals currently using PrEP will show higher engagement with sexual health services, psychosocial support, and other social resources compared to those who have never used PrEP. The study will follow participants over a 12-month period to assess these differences in service utilization. By focusing on a key population, the study seeks to provide insights into the broader impacts of PrEP on health behaviors and service engagement.

Who should consider this trial

Good fit: Ideal candidates for this study are HIV-negative individuals aged 18 and older residing in the Washington, DC metropolitan area, with either no prior PrEP use or currently on daily oral PrEP or LAI-PrEP.

Not a fit: Patients who are under 18 years old, do not reside in the Washington, DC area, or have a history of mental health conditions that prevent compliance may not benefit from this study.

Why it matters

Potential benefit: If successful, this study could enhance understanding of how PrEP use can lead to increased access to essential health and social services for at-risk populations.

How similar studies have performed: While this study focuses on a specific population and context, similar studies have shown that PrEP can positively influence health service utilization, suggesting potential for success.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

* age of 18 years or above;
* confirmed HIV-negative status;
* residence in the Washington, DC metropolitan area;
* one of the following PrEP profiles (PrEP naïve \[no history of any PrEP use in the past\] currently on daily oral PrEP or receiving LAI-PrEP).

Exclusion Criteria:

* being younger than18 years of age
* being unable to speak and/or read English
* a reported residence outside of the defined Washington, DC metropolitan area
* being unable or unwilling to provide written informed consent
* being unable to comply with the requirements of the protocol (i.e. persons with mental health conditions, persons who are intoxicated or incoherent for other reasons)
* evidence of suspected hepatoxicity

Where this trial is running

Washington D.C., District of Columbia

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions Pre-exposure ProphylaxisHIVHealth Behavior
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.